Why do young people and middle-aged and elderly people choose different medications for insomnia?

1. Young people vs. middle-aged and elderly people: The physiological manifestations of insomnia are completely different

Age Group

Common manifestations

The mechanism behind it

Young people ( 18-40 years old)

Difficulty falling asleep, tossing and turning, and unable to stop thinking

Mostly due to anxiety, stress, active arousal system, and delayed falling asleep

Middle-aged and elderly people (over 50 years old)

Light sleep, easy to wake up, early morning awakening, still tired after waking up

Reduced deep sleep, early biological clock, frequent nighttime awakenings

📌 They both suffer from insomnia, but the root causes are completely different :

       Young people ca n’t sleep

       Middle-aged and elderly people cannot sleep

 

2. Different symptoms require drugs with different mechanisms to respond

🟦 Common conditions among young people: difficulty falling asleep + nighttime anxiety

Recommended drug: Lemborexant

       The effect takes effect quickly, shortening the average time to fall asleep by 20 to 25 minutes

       Gently regulates the wakefulness system without inhibiting cognitive function

       Suitable for users who have " too active brains " and " can't stop at night "

📌 Applicable people : high-pressure workers, young mothers, students, anxiety-related sleep disorders

 

🟨 Common conditions among middle-aged and elderly people: light sleep, easy awakening, difficulty falling asleep again after waking up in the early morning

Recommended drug: Daridorexant

       The sleep structure is highly protective and significantly increases the proportion of deep sleep in stage N3

       The half-life is moderate (about 8 hours), and does not affect wakefulness the next day

       Improve morning fatigue, suitable for middle-aged and elderly people who need to maintain cognitive and emotional stability

📌 Applicable people : People over 50 years old, with memory loss, frequent night awakenings, or those at risk of cognitive decline

 

🟩 People with significant difficulty falling asleep + frequent nighttime awakenings (all ages)

Recommended drug: Suvorexant

       Long half-life ( 12 hours), suitable for sleep maintenance disorders

       Can cover the awakening system all night long to reduce the number of night awakenings

       Suitable for insomniacs with " anxiety before bedtime + easy waking up at night "

📌 Applicable people : People with rhythm disorder, frequent nighttime awakening, and frequent early awakening

 

3. The stronger the drug, the better. It is effective only when it is effective for the right disease .

Many users mistakenly believe that " sedatives are necessary for insomnia " , which results in:

       Young people feel drowsy during the day and become more and more afraid the more they eat

       Elderly people still wake up at night, and rebound is severe after stopping medication

ORAs (orexin receptor antagonists) are more suitable for classification matching because they:

       Start with the " awakening system " , no forced sedation, no cognitive side effects

       Can precisely act on delayed sleep onset or sleep maintenance disorders

       No addiction, can be used for a long time, no rebound after stopping the drug

 

Conclusion: Using the right medicine is more important than taking it

The truly scientific way to aid sleep is not to calm you blindly, but to find out what type of insomnia you have and then treat it accordingly.Young people and middle-aged and elderly people have different physiological bases, different stress sources, and different sleep structures, so naturally the way they use medication should also be different.Suvorexan, Lebrexan and Dalirexan are customized solutions for different types of insomniacs:It’s not about forcing yourself to fall asleep, but about helping you regain the ability to sleep .

Welcome to scroll down to the bottom of the page to add customer service to get a new customer discount

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.